long intergenic non-protein coding RNA 2084Genealiases: []
Q-omics provides the consensus-scored LINC02084 profile across patient tissues and cancer cell-line models. LINC02084 expression is associated with patient survival in 25 of 34 cancer types, with the highest sampling consensus in UVM. Among the 18 cancer types available for tumor–normal comparison, LINC02084 is differentially expressed in 12, with the highest sampling consensus in KIRC. Additionally, LINC02084 RNA expression shows 13,840 significant protein co-abundance associations, with the highest sampling consensus in GBM. Together, these results highlight UVM, KIRC, and GBM as cancer lineages where LINC02084 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02084 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02084 survival associations across molecular data types. LINC02084 RNA expression shows survival associations in the most cancer types (25). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02084 RNA expression–survival associations across cancer types. High LINC02084 expression shows unfavorable associations in UVM and THYM, but favorable associations in CESC, BRCA, HNSC and ESCA. The UVM Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify UVM as the clearest survival context for LINC02084 RNA expression.
This table summarizes LINC02084 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 12. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02084. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02084 shows lower tumor expression in THCA, LUSC, UCEC and LUAD and higher tumor expression in KIRC and HNSC. The KIRC box plot shows higher LINC02084 RNA expression in tumor versus normal tissue (log2 FC = +0.977, t-test p < 0.001).
This table shows molecular features associated with LINC02084 in patient tissues and cancer cell lines. In patient samples, LINC02084 shows the broadest associations at the RNA and protein expression levels, with GBM recurring as the lineage with the largest associated feature set.
